Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


CHESS ROBERT Create: Alert

All | News | Filings
Date FiledTypeDescription
02/09/2023 4 CHESS ROBERT (Director) has filed a Form 4 on Twist Bioscience Corp
Txns: Granted 8,212 shares @ $0
09/26/2022 4 CHESS ROBERT (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 5,100 shares @ $3.19, valued at $16.3k
09/20/2022 4 CHESS ROBERT (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 10,200 shares @ $0
Granted 20,400 options @ $3.47, valued at $70.8k
02/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2021 4 CHESS ROBERT (Director) has filed a Form 4 on Twist Bioscience Corp
Txns: Sold 4,000 shares @ $120.1534, valued at $480.6k
10/25/2021 4 CHESS ROBERT (Director) has filed a Form 4 on Twist Bioscience Corp
Txns: Sold 3,700 shares @ $120.146, valued at $444.5k
10/21/2021 4 CHESS ROBERT (Director) has filed a Form 4 on Twist Bioscience Corp
Txns: Sold 300 shares @ $120, valued at $36k
09/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2021 4 CHESS ROBERT (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 2,106 shares @ $16.8, valued at $35.4k
Sold 3,524 shares @ $16.81, valued at $59.2k
Sold 91 shares @ $16.8, valued at $1.5k
Exercised 2,106 options to buy @ $13.8, valued at $29.1k
Exercised 3,524 options to buy @ $13.8, valued at $48.6k
Exercised 91 options to buy @ $13.8, valued at $1.3k
07/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/05/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
03/05/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/25/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/10/2020 4 CHESS ROBERT (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 8,000 shares @ $18.53, valued at $148.2k
Exercised 8,000 options to buy @ $9.24, valued at $73.9k
07/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/17/2020 4 CHESS ROBERT (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 7,803 shares @ $18.36, valued at $143.3k
Sold 197 shares @ $19.02, valued at $3.7k
Exercised 8,000 options to buy @ $9.24, valued at $73.9k
03/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/06/2020 4 CHESS ROBERT (Director) has filed a Form 4 on Twist Bioscience Corp
Txns: Granted 1,412 shares @ $0
Granted 5,648 options to buy @ $26.2, valued at $148k
10/09/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/01/2019 4 CHESS ROBERT (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 4,000 shares @ $17.99, valued at $72k
09/27/2019 4 CHESS ROBERT (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 6,500 shares @ $0
Granted 13,000 options @ $18.8, valued at $244.4k
10/30/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy